Hologic To Participate In Three Investor Conferences

BEDFORD, Mass., March 14, 2011 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Glenn Muir, Executive Vice President and Chief Financial Officer, will present at the following investor conferences in March:

  • Citi 2011 Global Healthcare Conference in New York City, on Thursday, March 3, 2011, at 9:30 a.m. (Eastern).
  • Raymond James 32nd Annual Institutional Investors Conference in Orlando, FL, on Tuesday, March 8, 2011, at 11:35 a.m. (Eastern).
  • Barclays Capital 2011 Global Healthcare Conference in Miami, FL, on Tuesday, March 15, 2011 at 2:00 p.m. (Eastern).

Please note that times are subject to change.

About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast Magnetic Resonance Imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications.

Deborah R. Gordon
Vice President, Investor Relations
Hologic, Inc.
Tel: 781.999.7716